Filings
Trends
Rankings
Learn
Home
/
Moors & Cabot, Inc.
/
Q2 2017 Filing
Moors & Cabot, Inc.
Q2 2017 Filing
Filed August 15, 2017
Portfolio Value
$601.8B
Holdings
509
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (509 positions)
#
Stock
Shares
Value
% Portfolio
Type
501
—
LADENBURG THALMAN FIN SVCS I
13,000
$30.0M
0.00%
502
—
CASI PHARMACEUTICALS INC
26,053
$27.0M
0.00%
503
DXLG
DESTINATION XL GROUP INC
10,000
$24.0M
0.00%
504
—
RAIT FINANCIAL TRUST
10,865
$23.0M
0.00%
505
—
BIOPHARMX CORP
40,000
$19.0M
0.00%
506
GSTEUR
GASTAR EXPL INC NEW
20,000
$18.0M
0.00%
507
—
FRONTIER COMMUNICATIONS CORP
11,372
$12.0M
0.00%
508
SNY
SANOFI
16,000
$6.0M
0.00%
509
SDRL
SEADRILL LIMITED
15,400
$5.0M
0.00%
Previous
Page 6 of 6